Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q2 2023 Earnings Call Transcript August 3, 2023
Ultragenyx Pharmaceutical Inc. misses on earnings expectations. Reported EPS is $-2.25 EPS, expectations were $2.11.
Operator: Good afternoon, and welcome to the Ultragenyx Second Quarter 2023 Financial Results Conference Call. [Operator Instructions]. It is now my pleasure to turn the call over to Joshua Higa, Vice President of Investor Relations.
Joshua Higa: Thank you. We have issued a press...
